ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

IPIX Innovation Pharmaceuticals Inc (CE)

0.0015
0.00 (0.00%)
May 20 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0.00
Bid Price
Ask Price
News -
Day High

Low
0.0001

52 Week Range

High
0.021

Day Low
Company Name Stock Ticker Symbol Market Type
Innovation Pharmaceuticals Inc (CE) IPIX OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 0.0015 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.0015
Trades Volume Avg Volume 52 Week Range
0 0.00 - 0.0001 - 0.021
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.0015 USD

Innovation Pharmaceuticals Inc (CE) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
0 514.01M 342.36M 0 -3.17M -0.01 0.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Innovation Pharmaceuticals (CE) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No IPIX Message Board. Create One! See More Posts on IPIX Message Board See More Message Board Posts

Historical IPIX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.00130.006850.00130.001406150,9810.000215.38%
1 Month0.00420.0080.00010.0020978193,210-0.0027-64.29%
3 Months0.007250.01950.00010.0109446481,208-0.00575-79.31%
6 Months0.00770.01950.00010.0090797638,890-0.0062-80.52%
1 Year0.01990.0210.00010.0105021477,881-0.0184-92.46%
3 Years0.200.540.00010.0992466999,589-0.1985-99.25%
5 Years0.250.650.00010.1709251,293,961-0.2485-99.40%

Innovation Pharmaceuticals (CE) Description

An early stage developmental biopharmaceutical company...with six pharmaceutical compound candidates that are designed for treatment of diseases which may be either existing or diseases identified in the future. The Company will initially spend most of its efforts and resources on its anti-cancer compound, Kevetrin, for the treatment of head and neck cancers.

Your Recent History

Delayed Upgrade Clock